MILAN — Immune-based treatments continue to fall short in myelodysplastic syndromes (MDS). Now, experts from the European Hematology Association’s (EHA) Specialized Working Group on MDS here at the ...
Recovery from deadly influenza infection may hinge on helping the lungs heal in addition to stopping the virus, according to a new study in mice, which shows that pairing modest antiviral therapies ...
On November 14 and 15, 2022, the National Cancer Policy Forum will host a public workshop that will examine the current challenges related to resistance to immune modulator therapies for cancer and ...
Baylor College of Medicine and Site Tx, Inc. are collaborating to develop novel small-molecule drugs that allow for the fine-tuning of immune responses in multiple disease. Focusing on small molecule ...
C-type lectin receptors (CLRs) are a versatile family of transmembrane proteins pivotal in pathogen recognition and the initiation of immune responses. By recognising carbohydrate motifs on microbes, ...
SIRT1 represents a mechanistically validated target with notable progress in early-stage drug development for MASLD. With further in-depth analysis of its regulatory network and continued optimization ...
"These findings suggest that consciously generated positive expectations can engage reward circuitry to influence immune function, a process that may be leveraged for non-invasive immune modulation," ...
Late breaker abstract presentation to showcase clinical validation of first-in-class oral small molecule AX-158 in cohort of patients with psoriasis Full dataset to expand on previously announced ...
NORTH CHICAGO, Ill.--(BUSINESS WIRE)--32 Biosciences, a gastrointestinal (GI)-focused biotechnology company pioneering gut mucosal-immune science to prevent and treat GI diseases, today announced that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results